Italia markets open in 2 hours 34 minutes

Merck & Co., Inc. (MRK)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
128,12+0,75 (+0,59%)
Alla chiusura: 04:02PM EST
128,10 -0,02 (-0,02%)
Dopo ore: 07:59PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente127,37
Aperto127,44
Denaro0,00 x 900
Lettera0,00 x 800
Min-Max giorno126,80 - 128,16
Intervallo di 52 settimane99,14 - 129,29
Volume4.774.593
Media Volume8.589.767
Capitalizzazione324,659B
Beta (5 anni mensile)0,39
Rapporto PE (ttm)915,14
EPS (ttm)0,14
Prossima data utili25 apr 2024
Rendimento e dividendo (futuro)3,08 (2,40%)
Data ex dividendo14 mar 2024
Stima target 1A134,18
  • GlobeNewswire

    Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

    PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology RAHWAY, N.J. and SAN DIEGO, April 16, 2023 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) (Nasdaq: RXDX) today announced that the companies have entered into a